Revenue Breakdown
Composition ()
No data
Revenue Streams
Kamada Ltd (KMDA) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Proprietary Products, accounting for 85.9% of total sales, equivalent to $38.44M. Another important revenue stream is Distribution. Understanding this composition is critical for investors evaluating how KMDA navigates market cycles within the Pharmaceuticals industry.
Profitability & Margins
Evaluating the bottom line, Kamada Ltd maintains a gross margin of 42.04%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 16.63%, while the net margin is 11.27%. These profitability ratios, combined with a Return on Equity (ROE) of 7.86%, provide a clear picture of how effectively KMDA converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, KMDA competes directly with industry leaders such as BCRX and NVAX. With a market capitalization of $483.95M, it holds a significant position in the sector. When comparing efficiency, KMDA's gross margin of 42.04% stands against BCRX's 98.63% and NVAX's 69.49%. Such benchmarking helps identify whether Kamada Ltd is trading at a premium or discount relative to its financial performance.
